The 4G/5G Polymorphism of the Plasminogen Activator Inhibitor-1 Gene in Patients with Coronary Heart Disease

Journal of Capital Medical University ›› 2001, Vol. 22 ›› Issue (2): 119-122.

• 论著 • Previous Articles Next Articles

The 4G/5G Polymorphism of the Plasminogen Activator Inhibitor-1 Gene in Patients with Coronary Heart Disease

Fu Yan¹, Wang Xudong¹, Zhai Yanling¹, Fan Zheng², Yang Ling¹, Zhu Yuqing¹, Qi Yahui², Zhao Xiangyin¹

1. Emergency Department, Beijing Tongren Hospital, Affiliate of Capital University of Medical Sciences;2. Laboratory Centre, Capital University of Medical Sciences

Received:2001-01-03 Revised:1900-01-01 Online:2001-04-15 Published:2001-04-15

Abstract

Abstract: WT5BZ]To investigate the relationship between 4G/5G polymorphism of the plasminogen activator inhibitor-1(PAI-1)gene and coronary heart disease(CHD), genotype at this polymorphism was determined in 123 cases with CHD and 172 controls by polymerase chain reaction using the allele specific primers. Plasma PAI-1 antigen level, PAI activity, cholesterol and triglyceride were measured and body mass index was calculated from all the subjects. The group of CHD had a high number of homozygotes for the deleted allele(4G/4G)of the PAI-1 gene compared with the control(47.2% vs 22.1%, P< 0.05). Mean plasma PAI-1 antigen level and PAI activity varied significantly among the 3 genotypes, being higher in 4G/4G subjects than in 5G/5G subjects 〔(40.87±0.99)μg/L〕 vs 〔(38.14±1.0)μg/L〕, 〔(750±350)U/L〕 vs(650±270)U/L, P<0.05). The PAI-1 4G/5G polymorphism correlated with PAI-1 antigen level to some extent accounts for the development of CHD.

Key words: coronary heart disease, plasminogen activator inhibitor-1, gene polymorphism

CLC Number:

R541.4

Fu Yan;Wang Xudong;Zhai Yanling;Fan Zheng;Yang Ling;Zhu Yuqing;Qi Yahui;Zhao Xiangyin. The 4G/5G Polymorphism of the Plasminogen Activator Inhibitor-1 Gene in Patients with Coronary Heart Disease[J]. Journal of Capital Medical University, 2001, 22(2): 119-122.

[1]	Huo Bixiu, Jia Hongxiao, , Ning Yanzhe, Zheng Sisi. Abnormal top-down and bottom-up attention patterns in patients suffering from coronary heart disease with heart qi deficiency syndrome [J]. Journal of Capital Medical University, 2025, 46(3): 455-462.
[2]	Huo Bixiu, Jia Hongxiao, , Ning Yanzhe. Research progress of cognitive function decline in patients with coronary heart disease [J]. Journal of Capital Medical University, 2025, 46(3): 496-502.
[3]	Hou Dongyan, Feng Dan, Li Na. Efficacy of dapagliflozin in treatment of coronary heart disease and heart failure with preserved ejection fraction patients [J]. Journal of Capital Medical University, 2024, 45(4): 715-720.
[4]	He Sha, Yuan Mengwei, Gao Yan, Gou Dongyun, Li Yang, Qiu Huiqing. Association between ApoE gene polymorphism and cardiovascular and cerebrovascular diseases in Hebei Han nationality [J]. Journal of Capital Medical University, 2023, 44(5): 852-858.
[5]	Gao Xia, Hu Yanjin, Yao Zhi, Wang Guang. Correlation between triglyceride glucose index and severity of coronary artery disease in patients with newly diagnosed coronary heart disease [J]. Journal of Capital Medical University, 2023, 44(3): 381-386.
[6]	Zhang Jianxiong, Li Dandan, Hu Mengmeng, Cheng Xuewei, Dong Ruihua. Relationship between carboxylesterase 1 and carboxylesterase 2 gene expression levels and body mass index, and gene polymorphism analysis [J]. Journal of Capital Medical University, 2023, 44(1): 13-19.
[7]	Song Limin, Li Siyuan, Li Jun, Zhao Huirong, Li Jiajia, Wang Shuang. Relationship between polymorphism and mutation of LRP5 and SOST gene with bone metabolism in postmenopausal type 2 diabetic mellitus women in Shihezi,Xinjiang [J]. Journal of Capital Medical University, 2022, 43(2): 269-274.
[8]	Xia Ning, Nie Xiuhong, Wang Hao, Fan Xiaojun. Association of OSA and asthma with the incidence rate of coronary heart disease [J]. Journal of Capital Medical University, 2022, 43(1): 138-142.
[9]	Xu Xiaohan, Cheng Yujing, Liu Xiaoli, Zhou Yujie. Guardian of the heart——Professor Zhou Yujie [J]. Journal of Capital Medical University, 2020, 41(5): 844-848.
[10]	Wei Jiajie, Jiao Jie, Zhou Yingsheng. Clinical characteristics and risk factors of obstructive sleep apnea syndrome in patients with type 2 diabetes mellitus [J]. Journal of Capital Medical University, 2020, 41(1): 35-39.
[11]	Xiong Xiaowei, Guo Caixia, Xu Xiaowei, Mu Liying, Hu Hongyu, Chen Wei, Chen Buxing. Associations of plasma trimethylamine N-oxide and its precursors with coronary heart disease [J]. Journal of Capital Medical University, 2020, 41(1): 99-102.
[12]	Xia Yong, Zhang Jianqing, Wang Shaoxia, Chen Dan, Ji Jianmin. Effects of combined sacubitril/valsartan and metoprolol succinate sustained release tablets on patients who suffer from the coronary heart disease with chronic heart failure [J]. Journal of Capital Medical University, 2020, 41(1): 113-118.
[13]	Zhao Yanming, Wang Chengshuo, Zhao Yali, Zhang Yuan, Zhang Luo. Association between human leukocyte antigenⅡ (HLA-Ⅱ) gene polymorphism and house dust mites-sensitive allergic rhinitis in Chinese subjects [J]. Journal of Capital Medical University, 2017, 38(5): 688-694.
[14]	Yang Yaoguo, Chen Zhong, Tang Xiaobin, Kou Lei, Wu Zhangmin, Liu Hui, Wang Sheng, Zhang Zheng, Jia Yunfeng, He Nan. Clinical characteristics and perioperative management of abdominal aortic aneurysm complicated with coronary heart disease [J]. Journal of Capital Medical University, 2015, 36(1): 23-27.
[15]	CHEN Wenming, LI Dongbao, CHEN Hui, LI Hongwei, ZHAO Jie, ZHAO Huiqiang, LIANG Siwen, DING Xiaosong. Predictors for rapid progression of non-culprit coronary lesions after successful stent implantation in culprit lesions [J]. Journal of Capital Medical University, 2013, 34(1): 90-94.

The 4G/5G Polymorphism of the Plasminogen Activator Inhibitor-1 Gene in Patients with Coronary Heart Disease

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments